Cost Curve News - News - https://www.costcurvenews.com/blog/page/6/

TrumpRx Prices Are Attracting Attention from Other Supply Chain Heavyweights

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

Bausch Pulls Its Meds from Medicaid (and 340B)

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

The Wall Street Journal Is Asking Tough Questions About Connections Between the White House and BlinkRx

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

Amgen to Offer Repatha Directly to Patients for Less Than Other Countries Are Paying

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

Fifteen More Drugs Will Get Price Controls Next Month. Here’s How to Prepare

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

Putting All of the Pharm-to-Table Resources in One Place

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

Cost Curve News

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv

3 months ago

Keep Reading

TrumpRx Prices Are Attracting Attention from Other Supply Chain Heavyweights

Bausch Pulls Its Meds from Medicaid (and 340B)

The Wall Street Journal Is Asking Tough Questions About Connections Between the White House and BlinkRx

Amgen to Offer Repatha Directly to Patients for Less Than Other Countries Are Paying

Fifteen More Drugs Will Get Price Controls Next Month. Here’s How to Prepare

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Latest Posts

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

Popular

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

The Most Interesting Drug Pricing News of the Year Is Flying Under the Radar

We’re Back at It. Here Are the Four Key Holiday Storylines to Get You Caught Up.

Happy Festivus! Cost Curve Readers Have Some Grievances They’d Like to Air.

Christmas Comes Early for the Wonks, With CMS Demonstrations and MFN Announcements

Latest News

Will Pharma’s MFN Deals to Change the Drug-Price Reality for U.S. Patients or European Governments?

Empty Offices, Full Coffers: A Journalistic Expose Examines How PBMs Use Group Purchasing Organizations to Profit

Subcribe To Newsletter